Literature DB >> 30816943

CHEK2 Alleles Predispose to Renal Cancer in Poland.

Elzbieta Zlowocka-Perlowska1, Steven A Narod2,3, Cezary Cybulski1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30816943     DOI： 10.1001/jamaoncol.2019.0022

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  4 in total

1.  High risk of breast cancer in women with biallelic pathogenic variants in CHEK2.

Authors:  Irene Rainville; Shanell Hatcher; Eric Rosenthal; Katie Larson; Ryan Bernhisel; Stephanie Meek; Heidi Gorringe; Erin Mundt; Susan Manley
Journal:  Breast Cancer Res Treat       Date:  2020-01-28       Impact factor: 4.872

Review 2.  CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather than Checkmate.

Authors:  Lenka Stolarova; Petra Kleiblova; Marketa Janatova; Jana Soukupova; Petra Zemankova; Libor Macurek; Zdenek Kleibl
Journal:  Cells       Date:  2020-12-12       Impact factor: 6.600

3.  Risk of Second Primary Thyroid Cancer in Women with Breast Cancer.

Authors:  Monika Cieszyńska; Wojciech Kluźniak; Dominika Wokołorczyk; Cezary Cybulski; Tomasz Huzarski; Jacek Gronwald; Michał Falco; Tadeusz Dębniak; Anna Jakubowska; Róża Derkacz; Wojciech Marciniak; Marcin Lener; Karolina Woronko; Dominika Mocarz; Piotr Baszuk; Marta Bryśkiewicz; Steven A Narod; Jan Lubiński
Journal:  Cancers (Basel)       Date:  2022-02-15       Impact factor: 6.639

4.  Frequency of pathogenic germline variants in cancer susceptibility genes in 1336 renal cell carcinoma cases.

Authors:  Bryndis Yngvadottir; Avgi Andreou; Laia Bassaganyas; Alexey Larionov; Alex J Cornish; Daniel Chubb; Charlie N Saunders; Philip S Smith; Huairen Zhang; Yasemin Cole; Genomics England Research Consortium; James Larkin; Lisa Browning; Samra Turajlic; Kevin Litchfield; Richard S Houlston; Eamonn R Maher
Journal:  Hum Mol Genet       Date:  2022-08-25       Impact factor: 5.121
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.